Follow the company. Check the evidence.
Public records connected to stocks traded by Congress. See what changed, when it became public, and the original source.
INCY: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.
1 congressional household disclosed purchases in the past 90 days. See the trades
INCY: Financial results
Filed 8-K for an event or period dated 2026-10-29. Financial results.
1 congressional household disclosed purchases in the past 90 days. See the trades
Issuance of Priority Review Voucher; Rare Pediatric Disease Product; ATEBRIOZ (Zilurgisertib)
The Food and Drug Administration (FDA) is announcing the issuance of a priority review voucher to the sponsor of a rare pediatric disease product application. The Federal Food, Drug, and Cosmetic Act (FD&C Act) authorizes FDA to award priority review vouchers to sponsors of approved rare pediatric disease product applications that meet certain criteria. FDA is required to publish notice of the award of the priority review voucher. FDA has determined that ATEBRIOZ (zilurgisertib), approved September 25, 2026, manufactured by Incyte Corporation meets the criteria for a priority review voucher.
Public: Oct 28, 2026Original source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
INCY: third_quarter 2026 lobbying report
Issues related to 340B Issues related to Medicaid rebates; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to CMMI demos (Guarding U.S. Medicare Against Rising Drug Costs (GUARD) and Global Benchmark for Efficient Drug Pricing (GLOBE)); Issues related to Senate Finance Dear Colleague process; Education around access to innovative therapies in dermatology; Issues related to the Orphan Cures Act
Public: Oct 20, 2026, 3:54 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
INCY: third_quarter 2026 lobbying report
Issues related to Medicaid Drug Rebate program rule. Public Law 119-21: One Big Beautiful Bill Act, as it relates to H.R.946 - ORPHAN Cures Act. Issues related to drug pricing including potential legislation to impose Most Favored Nation pricing in Medicare. CMS Guard demonstration project".
Public: Oct 20, 2026, 3:28 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
INCY: third_quarter 2026 lobbying report
H.R. 946 / S. 1862, Orphan Cures Act implementation H. Res. 1331, Expressing support for "Hidradenitis Suppurativa Awareness Week" Issues related to Medicaid rebates Issues related to implementation of the Inflation Reduction Act Issues related to the 340B Drug Pricing Program Issues related to drug cost and pricing Education around access to innovative therapies in dermatology
Public: Oct 20, 2026, 12:39 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
INCY: third_quarter 2026 lobbying report
Issues related to Medicare Part D and Part B Pricing Reform; Issues related to Medicaid Rebates; Issues related to Health and Human Services Center for Medicare and Medicaid Innovation GUARD Demo; Issues related to Medicare coverage of Vitilligo. Issues related to H.Res. 1331 - Expressing support for the designation of June 1, 2026, through June 7, 2026, as "Hidradenitis Suppurativa Awareness Week".
Public: Oct 19, 2026, 6:28 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
INCY: second_quarter 2026 lobbying report
Healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry. Healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry.
Public: Oct 19, 2026, 7:28 AM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
INCY: third_quarter 2026 lobbying report
Issues relating to CMS coverage and reimbursement policies.
Public: Oct 18, 2026, 8:08 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
INCY: Other company developments
Filed 8-K for an event or period dated 2026-08-31. Other company developments.
1 congressional household disclosed purchases in the past 90 days. See the trades
INCY: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-06-30. Read the company report for its disclosures.
1 congressional household disclosed purchases in the past 90 days. See the trades
INCY: Financial results
Filed 8-K for an event or period dated 2026-07-28. Financial results.
1 congressional household disclosed purchases in the past 90 days. See the trades
Granting of Requests for Early Termination of the Waiting Period Under the Premerger Notification Rules
A Notice notice explicitly mentions the company. Read the cited text for its role.
Public: Jul 21, 2026Original source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
INCY: second_quarter 2026 lobbying report
Issues related to Medicaid Drug Rebate program rule. Public Law 119-21: One Big Beautiful Bill Act, as it relates to H.R.946 - ORPHAN Cures Act. Issues related to drug pricing.
Public: Jul 20, 2026, 2:38 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
INCY: second_quarter 2026 lobbying report
Issues related to 340b Issues related to Medicaid rebates; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to CMMI demos (Guarding U.S. Medicare Against Rising Drug Costs (GUARD) and Global Benchmark for Efficient Drug Pricing (GLOBE)); Issues related to Senate Finance Dear Colleague process
Public: Jul 20, 2026, 2:09 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
INCY: second_quarter 2026 lobbying report
H.R. 946 / S. 1862, Orphan Cures Act implementation H. Res. 1331, Expressing support for "Hidradenitis Suppurativa Awareness Week" S. 2658, Medication Affordability and Patent Integrity Act Issues related to Medicaid rebates Issues related to implementation of the Inflation Reduction Act Issues related to the 340B Drug Pricing Program Issues related to drug cost and pricing Education around access to innovative therapies in dermatology
Public: Jul 20, 2026, 2:01 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
INCY: second_quarter 2026 lobbying report
Issues related to Medicare Part D and Part B Pricing Reform; Issues related to Medicaid Rebates; Issues related to Health and Human Services Center for Medicare and Medicaid Innovation GUARD Demo. Issues related to H.Res. 1331 - Expressing support for the designation of June 1, 2026, through June 7, 2026, as "Hidradenitis Suppurativa Awareness Week".
Public: Jul 19, 2026, 4:11 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
INCY: second_quarter 2026 lobbying report
Issues relating to CMS coverage and reimbursement policies.
Public: Jul 16, 2026, 3:58 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
INCY: Other company developments
Filed 8-K for an event or period dated 2026-07-06. Other company developments.
1 congressional household disclosed purchases in the past 90 days. See the trades
INCY: second_quarter 2026 lobbying report
Healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry. Healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry.
Public: Jul 5, 2026, 5:59 AM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
INCY: Other company developments
Filed 8-K for an event or period dated 2026-06-22. Other company developments.
1 congressional household disclosed purchases in the past 90 days. See the trades
INCY: 8-K company filing
Filed 8-K for an event or period dated 2026-06-08. Read the company report for its disclosures.
1 congressional household disclosed purchases in the past 90 days. See the trades
INCY: Other company developments
Filed 8-K for an event or period dated 2026-06-08. Other company developments.
1 congressional household disclosed purchases in the past 90 days. See the trades
INCY: amended insider filing
An amended ownership report was filed. Read the original and amendment before comparing transactions.
1 congressional household disclosed purchases in the past 90 days. See the trades
INCY: amended insider filing
An amended ownership report was filed. Read the original and amendment before comparing transactions.
1 congressional household disclosed purchases in the past 90 days. See the trades
Connections describe public records, not evidence of wrongdoing or a prediction of returns. Event dates can precede publication by days or months. When a source has no public-release timestamp, we show when we first observed it.
Source coverage
Coverage is growing across companies already tracked here. A scan can return no matching records. This feed is not a complete record of every filing or agency action.
- SEC EDGAR
- Current across tracked companies505 of 505 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 12:26 PM EST
- USAspending
- Collection in progress96 of 548 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 12:27 PM EST
- SAM.gov
- Awaiting company connections
- Lobbying disclosures
- Not yet scanned0 of 548 companies scanned in the past 12 hours
- Congress.gov
- Current across tracked companies5 of 5 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 12:27 PM EST
- Federal Register
- Collection in progress288 of 548 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 12:27 PM EST
- Regulations.gov
- Collection in progress29 of 53 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 12:28 PM EST
- FEC campaign finance
- Stale — refresh overdue0 of 548 companies scanned in the past 12 hoursLatest successful company scan: Nov 11, 2026, 1:28 PM EST